MedTrace Logo

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

NCT00049959 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2011-03-16

No results posted yet for this study

Summary

The purpose of the two studies is to determine whether an experimental therapy using a photoactive drug, verteporfin, in combination with direct light exposure of basal cell carcinoma of the skin can safely eliminate these skin tumors.

Conditions

Interventions

DRUG

verteporfin PDT

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • QLT Inc.

    lead INDUSTRY

Principal Investigators

  • Herma Neyndorff · QLT Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2004-03-31
Completion
2004-03-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00049959 on ClinicalTrials.gov